3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Large B-Cell, Diffuse
18
Lymphoma
12
Lymphoma, Non-Hodgkin
11
Lymphoma, Follicular
10
Lymphoma, Mantle-Cell
9
Leukemia, Lymphocytic, Chronic, B-Cell
9
Lymphoma, B-Cell, Marginal Zone
5
Leukemia, Hairy Cell
4
Burkitt Lymphoma
4
Recurrence
3
Neoplasms
3
Lymphoma, B-Cell
3
Leukemia
3
Waldenstrom Macroglobulinemia
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Lymphoproliferative Disorders
2
Infections
2
Epstein-Barr Virus Infections
2
beta-Thalassemia
1
Thalassemia
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Plasmablastic Lymphoma
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Multi-centric Castleman's Disease
1
Macular dystrophy, corneal type 1
1
Lymphatic Diseases
1
Lymphadenopathy
1
Leukemia, Prolymphocytic
1
Interventions
Nuclear Medicine Department, Hospital
6
Magnetic Resonance Spectroscopy
6
X-Rays
5
Specimen Handling
5
Phantoms, Imaging
5
Biopsy
5
Temozolomide
4
Irinotecan
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
olaparib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
dinutuximab
2
Cyclophosphamide
2
trametinib
1
tazemetostat
1
talazoparib
1
saponin QA-21V1
1
palbociclib
1
lutetium Lu 177 dotatate
1
irinotecan sucrosofate
1
fludarabine phosphate
1
fludarabine
1
dabrafenib
1
Vincristine
1
Vemurafenib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroblastoma
×
Rituximab
×
30 days
×
Clear all
No trials found.